Safety Study of Infant Formula With Partially Hydrolized Whey

Status Withdrawn

Clinical Trial Summary

The study will be a randomized, double-blind, prospective trial. Newborn infants (enrollment age 0-14 days) will be assigned randomly to receive one of two products, provided in identical packages except for the lid color. Neither the investigators nor the parents will know which product the infant is receiving.

The infants will be monitored at study enrollment, and at 4, 8, and 12 weeks of age.

There will be two study groups, each receiving one of the following formulas:

1. The new partially hydrolyzed whey formula (NF) - Materna cow's milk infant formula containing partially hydrolyzed whey protein, produced and packaged by Materna Laboratories, Maabarot.

2. The currently marketed partially hydrolyzed whey formula (CF) - Nan HA, produced by Nestlé. In order to maintain blinding, the Nan HA will be repacked in packaging identical to the Materna product, except for the lid color

Clinical Trial Description

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00548106
Study type	Interventional
Source	Soroka University Medical Center
Contact
Status	Withdrawn
Phase	N/A

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04226586` - Nutritional Stimulation of Growth in Children With Short Stature	N/A
Terminated	`NCT03016195` - Evaluation of the Normal Range of Urinary Sodium Levels in Healthy Newborn Babies	N/A
Active, not recruiting	`NCT01809548` - Preterm Infants on Early Solid Foods	N/A
Completed	`NCT01475357` - Intestinal Function in Neonates With Complex Congenital Heart Disease	N/A
Completed	`NCT02136966` - Joint Infant and Young Child Nutrition Program and Malnutrition Prevention	N/A
Active, not recruiting	`NCT04565314` - ELICIT 2.0: Pilot Study of the Effect of Maternal Protein Supplementation During Lactation on Childhood Growth	N/A
Recruiting	`NCT04809350` - Human Milk Fortification With Adjustable Versus Targeted Method	N/A
Completed	`NCT02515266` - Additional Protein Fortification in Extremely Low Birth Weight Infants	N/A
Recruiting	`NCT04294368` - Targeted Fortification of Donor Breast Milk in Preterm Infants	N/A
Terminated	`NCT03532555` - Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia	N/A
Withdrawn	`NCT02999945` - Optimal Growth of Preterm Infants With Growth Restriction	N/A
Completed	`NCT01909661` - Tolerance of Infants With Cow's Milk Protein Allergy to Extensively Hydrolyzed Rice Protein or Casein Infant Formulas	Phase 2
Not yet recruiting	`NCT04640805` - Targeted Fortification of Pasteurized Donor Human Milk	N/A
Completed	`NCT01603368` - Prophylactic Probiotics to Extremely Low Birth Weight Prematures	Phase 2
Withdrawn	`NCT01314508` - Increlex Treatment of Children With Chronic Liver Disease and Short Stature	N/A
Terminated	`NCT00490100` - Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1	Phase 1/Phase 2
Completed	`NCT04587271` - Nutritional Impact of Moringa Oleifera Leaf Supplementation in Mothers and Children	N/A
Completed	`NCT01034735` - r-hGH Liquid Multidose Versus Freeze-dried Multidose Bioequivalence Trial	Phase 1
Active, not recruiting	`NCT03761498` - Is There a Microbiome Associated With Poor Growth in Preterm Infants?
Not yet recruiting	`NCT03522558` - Medical Nutrition Therapy for Medically Complex Infants in the Pediatric Outpatient Setting	N/A